KRIS HOWARD M.D. NPI 1740283019

NPI Details

Kris Howard, M.D. is a procedural dermatology dermatology in Odessa, TX with 41 years of experience. The provider is procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers). Kris Howard, M.D. NPI is 1740283019. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Graduation Year:1985

The provider's business location address is:

8141 DORADO DRIVE
ODESSA, TX
ZIP 79765
Phone: (432) 563-3113
Fax: (432) 563-4206

The NPI 1740283019 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Biopsy of ear (HCPCS:69100)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm (HCPCS:17263)
• Biopsy of lip (HCPCS:40490)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm (HCPCS:11643)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/31/2005 and was last updated on 11/17/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.